{"id":"https://openalex.org/W2137228730","doi":"https://doi.org/10.1016/j.jalz.2008.05.438","title":"O3\u201004\u201307: Tau aggregation inhibitor (TAI) therapy with rember\u2122 arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks","display_name":"O3\u201004\u201307: Tau aggregation inhibitor (TAI) therapy with rember\u2122 arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks","alternate_titles":[],"publication_year":2008,"publication_date":"2008-07-01","ids":{"openalex":"https://openalex.org/W2137228730","doi":"https://doi.org/10.1016/j.jalz.2008.05.438","mag":"2137228730"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2008.05.438","doi":"https://doi.org/10.1016/j.jalz.2008.05.438","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2008.05.438","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2137228730"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066994255","display_name":"Claude M. Wischik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Claude M. Wischik","raw_affiliation_strings":["University of Aberdeen, Aberdeen, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Aberdeen, Aberdeen, United Kingdom","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054173992","display_name":"Peter Bentham","orcid":"https://orcid.org/0000-0002-6443-3353","observed_orcids":["https://orcid.org/0000-0002-6443-3353"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Bentham","raw_affiliation_strings":["University of Aberdeen, Aberdeen, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Aberdeen, Aberdeen, United Kingdom","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059573791","display_name":"Damon Wischik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Damon J. Wischik","raw_affiliation_strings":["University College London United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052859283","display_name":"Kwang Meng Seng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101736","display_name":"TauRx Pharmaceuticals (Singapore)","ror":"https://ror.org/015frs841","country_code":"SG","type":"company","lineage":["https://openalex.org/I4210101736"]}],"countries":["SG"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kwang Meng Seng","raw_affiliation_strings":["TauRx Therapeutics Ltd, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TauRx Therapeutics Ltd, Singapore, Singapore","institution_ids":["https://openalex.org/I4210101736"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5066994255"],"corresponding_institution_ids":["https://openalex.org/I195460627"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":5.0077,"has_fulltext":false,"cited_by_count":125,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96538902,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"4","issue":"4S_Part_5","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methylene-blue","display_name":"methylene blue","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7526549100875854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6367831230163574},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.49525776505470276},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4867699146270752},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.48199668526649475},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4354396164417267},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3831973671913147},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.36321359872817993},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3231673240661621},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.260539710521698},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2008.05.438","doi":"https://doi.org/10.1016/j.jalz.2008.05.438","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2008.05.438","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2035005116","https://openalex.org/W2046102375","https://openalex.org/W350976382","https://openalex.org/W2291084186","https://openalex.org/W2115776368","https://openalex.org/W2553774099","https://openalex.org/W2463554686","https://openalex.org/W2354381498","https://openalex.org/W2189590432","https://openalex.org/W2007159737"],"abstract_inverted_index":{"Neurofibrillary":[0],"degeneration":[1],"is":[2,311],"correlated":[3],"with":[4,108,116,250,309],"clinical":[5],"dementia.":[6],"Methylthioninium":[7],"chloride":[8],"(MTC,":[9],"rember)":[10],"dissolves":[11],"Tau":[12,23,40,52,299],"polymers":[13],"(Paired":[14],"Helical":[15],"Filaments)":[16],"isolated":[17],"from":[18],"AD":[19,81,120,197,213,223,320],"brain,":[20],"and":[21,46,50,77,84,100,149,155,230,257,282,288,318],"prevents":[22],"aggregation":[24],"in":[25,39,54,72,82,114,183,195,211,227,246,255,293],"cell":[26],"models":[27],"at":[28,97,158,168,186,327],"the":[29,55,92,137,165,187,199,215,220,247,303],"nanomolar":[30],"range":[31],"(0.15":[32],"\u2013":[33],"0.58":[34],"\u03bcM).":[35],"MTC":[36,96],"has":[37],"efficacy":[38,205,208,252,261,270,292],"transgenic":[41],"animal":[42],"models,":[43],"reversing":[44,51],"cognitive":[45,111],"other":[47],"behavioural":[48],"defects,":[49],"pathology":[53],"brain.":[56],"An":[57],"exploratory,":[58],"dose-range":[59],"finding,":[60],"parallel":[61],"design,":[62],"double-blind,":[63],"randomised,":[64],"placebo-controlled":[65],"trial":[66],"of":[67,94,136,140,153,179,222,291,331],"rember":[68,171,218,260,269,310],"monotherapy":[69,308],"was":[70,89,127,191,209,237,262],"conducted":[71],"332":[73],"subjects":[74,185],"meeting":[75],"DSM-IV":[76],"NINCDS-ADRDA":[78],"for":[79,276,316],"probable":[80],"UK":[83],"Singapore.":[85],"The":[86,124,233,268],"primary":[87],"objective":[88],"to":[90,129,177],"investigate":[91],"effects":[93],"oral":[95],"30,":[98],"60":[99],"100":[101],"mg":[102],"three":[103],"times":[104],"per":[105],"day,":[106],"compared":[107],"placebo,":[109],"on":[110,264],"function":[112],"(ADAS-cog)":[113],"patients":[115],"mild":[117,212,229,256,317],"or":[118],"moderate":[119,231,258,319],"stratified":[121],"by":[122,214,279,286,298],"CDR.":[123],"100mg":[125],"dose":[126],"found":[128],"have":[130,324],"a":[131,173,312],"formulation":[132],"defect":[133],"limiting":[134],"release":[135],"therapeutic":[138],"form":[139],"MTC.":[141],"Secondary":[142],"outcomes":[143,157],"included":[144],"MMSE,":[145],"CDRsb,":[146],"CGIC,":[147],"ADFACS":[148],"NPI.":[150],"Nested":[151],"studies":[152],"SPECT-":[154],"PET-scan":[156],"6":[159],"months":[160],"are":[161],"reported":[162],"separately.":[163],"In":[164],"prespecified":[166],"analysis":[167,271,281],"24":[169,201],"weeks,":[170],"produced":[172],"significant":[174,251],"improvement":[175],"relative":[176],"placebo":[178,193],"-5.4":[180],"ADAS-cog":[181,239],"units":[182,240,245],"CDR-moderate":[184],"60mg":[188],"dose.":[189],"There":[190],"no":[192],"decline":[194,242],"CDR-mild":[196],"over":[198,224],"first":[200,304],"weeks":[202,226],"preventing":[203],"initial":[204],"analysis,":[206,284],"although":[207],"demonstrated":[210,253],"SPECT-scan":[216],"outcomes.":[217,267],"stabilised":[219],"progression":[221],"50":[225],"both":[228],"AD.":[232,332],"overall":[234],"effect":[235],"size":[236],"-6.8":[238],"vs.":[241],"if":[243],"7.8":[244],"placebo/comparator":[248],"arm,":[249],"separately":[254],"subgroups.":[259],"confirmed":[263],"all":[265],"secondary":[266],"met":[272],"new":[273],"EMEA":[274],"guidelines":[275],"disease-modifying":[277,314],"therapy":[278],"slope":[280],"two-time-point":[283],"supported":[285],"SPECT":[287],"PET":[289],"evidence":[290,305],"brain":[294],"regions":[295],"strongly":[296],"affected":[297],"pathology.":[300],"This":[301],"represents":[302],"that":[306],"TAI":[307],"viable":[313],"treatment":[315],"which":[321],"may":[322],"also":[323],"preventative":[325],"application":[326],"preclinical":[328],"Braak":[329],"stages":[330]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2137228730","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
